Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

26,584 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Comparisons of Modified Post-Transplantation Cyclophosphamide and Granulocyte Colony-Stimulating Factor/Antithymocyte Globulin Regimens for Haploidentical Stem Cell Transplantation in Patients with Aplastic Anemia.
Li Y, Lu X, Wang N, Zhang X, Cao Y, Xiao Y, Meng F, Zhang D, You Y, Zou L, Cheng H, Guo J, Zhang Y, Huang Z, Yuan G, Wei J, Wang H, Xia L, Zhang Y. Li Y, et al. Among authors: lu x. Transplant Cell Ther. 2022 Jul;28(7):396.e1-396.e9. doi: 10.1016/j.jtct.2022.04.021. Epub 2022 May 3. Transplant Cell Ther. 2022. PMID: 35513253 Free article.
Comparison of outcomes of idarubicin intensified TBI-CY and traditional TBI-CY conditioning regimen for high-risk acute lymphoblastic leukemia undergoing allogeneic hematopoietic stem cell transplantation: A single center experience.
Wu Q, Zhang R, Wang H, You Y, Zhong Z, Hong M, Fang J, Li W, Shi W, Lu X, Hu Y, Xia L. Wu Q, et al. Among authors: lu x. Leuk Res. 2015 Aug 28:S0145-2126(15)30369-6. doi: 10.1016/j.leukres.2015.08.015. Online ahead of print. Leuk Res. 2015. PMID: 26340915
Anti-CD19 chimeric antigen receptor-modified T-cell therapy bridging to allogeneic hematopoietic stem cell transplantation for relapsed/refractory B-cell acute lymphoblastic leukemia: An open-label pragmatic clinical trial.
Jiang H, Li C, Yin P, Guo T, Liu L, Xia L, Wu Y, Zhou F, Ai L, Shi W, Lu X, Wang H, Tang L, Wei Q, Deng J, Jin R, Xiong W, Dong J, Mei H, Hu Y. Jiang H, et al. Among authors: lu x. Am J Hematol. 2019 Oct;94(10):1113-1122. doi: 10.1002/ajh.25582. Epub 2019 Aug 2. Am J Hematol. 2019. PMID: 31321805 Free article. Clinical Trial.
A report of clustered COVID-19 in a hematology ward.
Wu Y, Liu F, Fang Y, Lu X, Wu Y, Xia L, Hong M. Wu Y, et al. Among authors: lu x. Blood Adv. 2020 Jun 23;4(12):2736-2738. doi: 10.1182/bloodadvances.2020001982. Blood Adv. 2020. PMID: 32559290 Free PMC article. No abstract available.
Comparing the outcomes between TMLI and non-TMLI conditioning regimens for adult high-risk acute lymphoblastic leukemia patients undergoing allogeneic hematopoietic stem cell transplantation: a single-center experience.
Zhao X, Lu X, Tang L, Yan H, Chen W, Shi W, Zhong Z, You Y, Xia L, Hu Y, Wang H. Zhao X, et al. Among authors: lu x. Leuk Lymphoma. 2020 Dec;61(12):2859-2867. doi: 10.1080/10428194.2020.1789621. Epub 2020 Jul 10. Leuk Lymphoma. 2020. PMID: 32654551
26,584 results
You have reached the last available page of results. Please see the User Guide for more information.